Research / DE / Fundamental state Inspectable configuration
State dimensions Filing 0001558370-22-014113 General Corporate
Capex intensity 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.77% · OPTIONAL · VALID
Operating cash generation 74th Own-history percentile · N=19
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
15.46% · OPTIONAL · VALID
Share-count growth 15th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.shares_outstanding
-2.66% · CORE · VALID
Revenue growth 65th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
22.34% · CORE · VALID
Inventory pressure 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
64.68% · OPTIONAL · VALID
Operating margin 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
18.76% · CORE · VALID
R&D intensity 10th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
3.41% · OPTIONAL · VALID
SBC intensity 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.14% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 44 states Self-history eligible
Aug 1, 2021 8/8 normalized Level 3 Oct 31, 2021 7/7 normalized Level 3 Jan 30, 2022 8/8 normalized Level 3 May 1, 2022 8/8 normalized Level 3 Jul 31, 2022 8/8 normalized Level 3 Oct 30, 2022 7/7 normalized Level 3 Jan 29, 2023 8/8 normalized Level 3 Apr 30, 2023 8/8 normalized Level 3 Jul 30, 2023 8/8 normalized Level 3 Oct 29, 2023 7/7 normalized Level 3 Jan 28, 2024 7/7 normalized Level 3 Apr 28, 2024 7/7 normalized Level 3 Jul 28, 2024 7/7 normalized Level 3 Oct 27, 2024 7/7 normalized Level 3 Jan 26, 2025 7/7 normalized Level 3 Apr 27, 2025 7/7 normalized Level 3 Jul 27, 2025 7/7 normalized Level 3 Feb 1, 2026 7/7 normalized Level 3 May 3, 2026 7/7 normalized Level 3 Aug 2, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 1.14%
Current 1.77%
Delta 0.63% Cash Generation Increased
Previous 5.92%
Current 15.46%
Delta 9.54% Dilution Decreased
Previous -2.02%
Current -2.66%
Delta -0.64% Growth Increased
Previous 10.88%
Current 22.34%
Delta 11.46% Inventory Pressure Decreased
Previous 67.54%
Current 64.68%
Delta -2.86% Profitability Decreased
Previous 19.97%
Current 18.76%
Delta -1.21% R And D Intensity Increased
Previous 3.39%
Current 3.41%
Delta 0.02% Sbc Intensity Decreased
Previous 0.19%
Current 0.14%
Delta -0.05% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.